Join
Live feed
·
INSIDERFilingvia Quantisnow
Indaptus Therapeutics Inc. logo

CSO and Director Newman Michael James was granted 52,204 shares, increasing direct ownership by 107% to 101,074 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INDP· Indaptus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDP (Indaptus Therapeutics Inc.) and more on Quantisnow.